Trials / Unknown
UnknownNCT01393093
Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas
Clinical Trial of Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,840 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the effects of Transcatheter Arterial Chemoembolization (TACE) with KMG microsphere in treating advance-stage Hepatocellular Carinoma(HCC).
Detailed description
This is a prospective, multicentre, random, controlled clinical trial of Transcatheter Arterial Chemoembolization (TACE)with KMG Microsphere Treating Advance-stage Hepatocellular Carinomas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Therapeutic Chemoembolization | Transcatheter Arterial Chemoembolization |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2016-11-01
- Completion
- 2018-12-01
- First posted
- 2011-07-13
- Last updated
- 2017-06-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01393093. Inclusion in this directory is not an endorsement.